Garba M. Khalid

923 total citations
37 papers, 564 citations indexed

About

Garba M. Khalid is a scholar working on Pharmaceutical Science, Biomedical Engineering and Automotive Engineering. According to data from OpenAlex, Garba M. Khalid has authored 37 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 8 papers in Biomedical Engineering and 5 papers in Automotive Engineering. Recurrent topics in Garba M. Khalid's work include Drug Solubulity and Delivery Systems (8 papers), 3D Printing in Biomedical Research (6 papers) and Advanced Drug Delivery Systems (5 papers). Garba M. Khalid is often cited by papers focused on Drug Solubulity and Delivery Systems (8 papers), 3D Printing in Biomedical Research (6 papers) and Advanced Drug Delivery Systems (5 papers). Garba M. Khalid collaborates with scholars based in Nigeria, Italy and United Kingdom. Garba M. Khalid's co-authors include Paola Minghetti, Francesco Cilurzo, Umberto M. Musazzi, Francesca Selmin, Nashiru Billa, Silvia Franzè, Yusuf Hassan Wada, Marco Aldo Ortenzi, Abubakar Ibrahim Jatau and A. G. Usman and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Garba M. Khalid

34 papers receiving 538 citations

Peers

Countries citing papers authored by Garba M. Khalid

Since Specialization

Citations

This map shows the geographic impact of Garba M. Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garba M. Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garba M. Khalid more than expected).

Fields of papers citing papers by Garba M. Khalid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garba M. Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garba M. Khalid. The network helps show where Garba M. Khalid may publish in the future.

Co-authorship network of co-authors of Garba M. Khalid

This figure shows the co-authorship network connecting the top 25 collaborators of Garba M. Khalid. A scholar is included among the top collaborators of Garba M. Khalid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garba M. Khalid. Garba M. Khalid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	3D printing of dose-flexible crystalline solid dispersion tablets suitable for preclinical and first-in-human studies 2025 ·Journal of Pharmaceutical Sciences ·Garba M. Khalid, (unknown), (unknown), (unknown), (unknown), Celia Hughes, KH Kahler, (unknown), (unknown), (unknown), John A. Rogers, (unknown), Aifang Li, Zhaohui Lei, (unknown), (unknown), (unknown), Martin Rowland, Abdul W. Basit, Álvaro Goyanes	0
2	Advancing medication compounding: Use of a pharmaceutical 3D printer to auto-fill minoxidil capsules for dispensing to patients in a community pharmacy 2025 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), Garba M. Khalid, (unknown), (unknown), (unknown), (unknown), Abdul W. Basit, Carmen Alvarez‐Lorenzo, Álvaro Goyanes	16
3	CRITICAL ANALYSIS OF POWDER FLOW BEHAVIOUR OF DIRECTLY COMPRESSIBLE COPROCESSED EXCIPIENTS 2024 ·FUDMA Journal of Sciences ·(unknown), Garba M. Khalid, Abubakar Sadiq Wada, (unknown), (unknown), (unknown)	0
4	Exploring Nigerian pharmacists’ attitudes and perceptions to continuing education and professional development 2023 ·Pharmacy Education ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Garba M. Khalid	3
5	Factors influencing pharmacists and pharmaceutical scientists’ membership in professional organisations: an international survey 2023 ·Journal of Pharmaceutical Policy and Practice ·(unknown), (unknown), (unknown), Garba M. Khalid, (unknown), (unknown), (unknown), Renly Lim	1
6	Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment 2022 ·PLoS neglected tropical diseases ·Yusuf Hassan Wada, (unknown), Kazeem B. Yusuff, Chinwe Lucia Ochu, Yahaya Mohammed, Garba M. Khalid, (unknown), (unknown)	11
7	Falsified and substandard medicines trafficking: A wakeup call for the African continent 2022 ·Public Health in Practice ·Yusuf Hassan Wada, (unknown), (unknown), (unknown), (unknown), Garba M. Khalid	14
8	Assessment of unsafe disposal of unused and expired medicines practices among households in North-west Nigeria 2022 ·(unknown), Abubakar Ibrahim Jatau, Basira Kankia Lawal, (unknown), Ismaeel Yunusa, Abubakar Sadiq Wada, Garba M. Khalid, (unknown), (unknown), Mustapha Mohammed	1
9	Solid Dispersion Formulations by FDM 3D Printing—A Review 2022 ·Pharmaceutics ·Garba M. Khalid, Nashiru Billa	31
10	Increasing coverage of vaccination by pharmacists in Nigeria; an urgent need 2021 ·Public Health in Practice ·Yusuf Hassan Wada, (unknown), Aniekan Ekpenyong, Yusuff Adebayo Adebisi, (unknown), Garba M. Khalid	7
11	Review of pharmacologic and immunologic agents in the management of COVID-19 2021 ·Biosafety and Health ·Marzuq A. Ungogo, Mustapha Mohammed, (unknown), (unknown), Garba M. Khalid	6
12	Relevance of production method on the physical stability and in vitro biopharmaceutical performances of olanzapine orodispersible film 2021 ·International Journal of Pharmaceutics ·Francesca Selmin, Garba M. Khalid, Umberto M. Musazzi, Francesco Demartin, Paola Minghetti, Francesco Cilurzo	14
13	Dual burden of COVID-19 and TB in Africa 2021 ·Clinical Epidemiology and Global Health ·Yusuf Hassan Wada, (unknown), Shuaibu Saidu Musa, Garba M. Khalid, Don Eliseo Lucero‐Prisno	4
14	The Burden of Drug Abuse in Nigeria: A Scoping Review of Epidemiological Studies and Drug Laws 2021 ·Public health reviews ·Abubakar Ibrahim Jatau, Abubakar Sha’aban, (unknown), (unknown), Garba M. Khalid, (unknown), Abubakar Sadiq Wada, Mustapha Mohammed	47
15	Assessment of occupational violence towards pharmacists at practice settings in Nigeria 2020 ·Pharmacy Practice ·Garba M. Khalid, Umar Ibrahim, Abubakar Ibrahim Jatau, Yusuf Hassan Wada, (unknown), Marzuq A. Ungogo	11
16	Trends in the production methods of orodispersible films 2019 ·International Journal of Pharmaceutics ·Umberto M. Musazzi, Garba M. Khalid, Francesca Selmin, Paola Minghetti, Francesco Cilurzo	81
17	Binder and Disintegrant Performance of Native and Thermally Modified Dioscorea cayenensis Starches in Paracetamol Tablet Formulations 2019 ·Tropical Journal of Natural Product Research ·(unknown), Garba M. Khalid, (unknown), (unknown), (unknown), (unknown), (unknown)	2
18	Antibiotics self-medication among undergraduate pharmacy students in Northern Nigeria 2019 ·SHILAP Revista de lepidopterología ·Garba M. Khalid, Abubakar Ibrahim Jatau, Umar Ibrahim, (unknown), (unknown), Abubakar Sha’aban, (unknown)	7
19	Personalized orodispersible films by hot melt ram extrusion 3D printing 2018 ·International Journal of Pharmaceutics ·Umberto M. Musazzi, Francesca Selmin, Marco Aldo Ortenzi, Garba M. Khalid, Silvia Franzè, Paola Minghetti, Francesco Cilurzo	103
20	Drug interaction and its implication in clinical practice and personalized medicine 2015 ·National Journal of Physiology Pharmacy and Pharmacology ·Abdullahi Rabiu Abubakar, (unknown), Garba M. Khalid, Mainul Haque	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact